Concepedia

Kandavel Shanmugam

KS

22

Publications

1.4K

Citations

17

H-Index

1996

Active since

Affiliations

Ventana Research Corporation (United States)(Current)

Mayo Clinic in Arizona

Mayo Clinic

McGill University

Inserm

Kandavel Shanmugam is an author at Ventana Research Corporation (United States) specializing in medicine, gene expression, and oncology.

ORCID

Top concepts

Publications per year

1996–2024

22

Publications

22

MUC1 enhances invasiveness of pancreatic cancer cells by inducing epithelial to mesenchymal transition

Lopamudra Das Roy, Mahnaz Sahraei, Durai B. Subramani et al. · Oncogene · 2010 · 265 citations · Full text

, , +9

PBX and MEIS as Non-DNA-Binding Partners in Trimeric Complexes with HOX Proteins

Kandavel Shanmugam, Nancy C. Green, Isabel Rambaldi et al. · Molecular and Cellular Biology · 1999 · 168 citations · Full text

, , +19

Validation of <i>HER2</i> Amplification as a Predictive Biomarker for Anti–Epidermal Growth Factor Receptor Antibody Therapy in Metastatic Colorectal Cancer

Kanwal Pratap Singh Raghav, Jonathan M. Loree, Jeffrey S. Morris et al. · JCO Precision Oncology · 2019 · 126 citations

Platelet-Derived Growth Factor Receptor β–Mediated Phosphorylation of MUC1 Enhances Invasiveness in Pancreatic Adenocarcinoma Cells

Pankaj K. Singh, Yunfei Wen, Benjamin J. Swanson et al. · Cancer Research · 2007 · 107 citations

GIV/Girdin is a central hub for profibrogenic signalling networks during liver fibrosis

Inmaculada López-Sánchez, Ying Dunkel, Yoon-Seok Roh et al. · Nature Communications · 2014 · 99 citations · Full text

, , +14

Rows per page

1–5 of 22